medigraphic.com

2012, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2012; 50 (1)

Pelvic lymph node retrieval in cervical cancer

Ortiz-Mendoza CM, Acosta-Sánchez NA

Language: Spanish
References: 40
Page: 93-97
PDF size: 34.37 Kb.


ABSTRACT

Background: retrieve the largest number of lymph nodes provides information to know the patient prognosis with invasive cervical cancer undergoing radical hysterectomy. The aim was to evaluate the skill of the attending surgeon to identify and recover lymph nodes.
Methods: pelvic lymphadenectomy specimens obtained from patients with cervical cancer stages IA2-IIA undergoing radical hysterectomy were studied. The surgeon or the pathologist assessed the specimens to determine the number of recovered lymph nodes. The lymph node classification was: right, left, common and total.
Results: the surgeon evaluated nine pelvic dissection specimens and pathologist other nine. Right lymph nodes: surgeon 14.8 ± 8, pathology 7.3 ± 3 (p ‹ 0.01). Left lymph nodes: surgeon 14.3 ± 6, pathology 7 ± 2 (p ‹ 0.01). Common lymph nodes: surgeon 6.6 ± 5, pathology 5.8 ± 5 (p ns). Total lymph nodes: surgeon 35.7 ± 17, pathology 20.2 ± 7 (p ‹ 0.01). Specimens with fewer than 20 lymph nodes recovered: surgeon 1, pathologist 6 (p = 0.02). Metastatic lymph nodes: surgery 4, pathologist 2 (p = ns).
Conclusions: the surgeon may retrieve a larger number of lymph nodes of pelvic lymphadenectomy specimens.


REFERENCES

  1. Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, et al. Interest of pelvic and paraortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999;73(1):106-110.

  2. Abu-Rustum NR, Hoskin WJ. Radical abdominal hysterectomy. Surg Clin North Am 2001;81(4):815-828.

  3. Ho CM, Chien TY, Huang SH, Wu CJ, Shih BY, Chang SC. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 2004;93(2):458-464.

  4. Kim JH, Kim HJ, Hong S, Wu HG, Ha SW. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma. Gynecol Oncol 2005;96(2):407-414.

  5. Piura B, Rabinovich A, Friger M. Surgical pathologic factors in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection: association with administration of adjuvant radiotherapy and effect on survival. Eur J Gynaecol Oncol 2006;27(6):573- 578.

  6. Benedetti-Panici P, Manechi F, D’Andrea G, Cutillo G, Rabitti C, Congiu M, et al. Early cervical carcinoma. The natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer 2000;88(10):2267-2274.

  7. Benedetti-Panici P, Maneschi F, Cutillo G. Pelvic and aortic lymphadenectomy. Surg Clin North Am 2001;81(4):841- 858.

  8. Hughes SH, Steller MA. Radical gynecologic surgery for cancer. Surg Oncol Clin N Am 200514(3):607-631.

  9. Benedetti-Panici P, Scambia G, Baiocchi G, Matonti G, Capelli A, Mancuso S. Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies. Obstet Gyencol 1992;79(4):498-502.

  10. Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5(4):250-256.

  11. Pieterse QD, Kenter GG, Gaarenstroom KN, Peters AA, Willems SM, Fleuren GJ, et al. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol 2006;33(2):216-221.

  12. Bunt AM, Hermans J, van de Velde CJ, Sasako M, Hoefsloot FA, Fleuren G, et al. Lymph node retrieval in a randomized trial on western-type versus japanese-type surgery in gastric cancer. J Clin Oncol 1996;14(8):2289-2294.

  13. Rosai J. Gross techniques in surgical pathology. En: Rosai J, editor. Ackerman’s Surgical Pathology. Eighth edition. St LM, USA: Mosby; 1996. p. 13-28.

  14. Piver MS, Rutdledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44(2):265-272.

  15. Ramírez-Gaytán JL, Sánchez-Valdivieso EA, Soto-Pérez G, Muñoz-González D. Histerectomía radical en cáncer del cervix estadio 1-B-1. Ginecol Obstet Mex 1997; 66(2):41-47.

  16. Torres-Lobatón A, Rueda-Mesías M, Román-Bassaure E, Rojo-Herrera G, Barra-Martínez R. Complicaciones de la histerectomía radical en el manejo del cáncer cervicouterino estadios Ib y IIa. Experiencia en 145 pacientes. Ginecol Obstet Mex 1996;64(6):265-271.

  17. Horn LC, Braumann UD, Fischer U, Bilek K, Richter CE, Einenkel J. Occult tumor cells in pelvic lymph nodes and parametrial tissue of small-sized FIGO IB1 squamous cell carcinomas of the uterine cervix—results of a pilot study. Pathol Res Pract 2005;201(7):513-516.

  18. Girardi F, Haas J. The importance of the histologic processing of pelvic lymph nodes in the treatment of cervical cancer. Int J Gynecol Cancer 1993;3(1):12-17.

  19. Girardi F, Pickel H, Winter R. Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer. Gynecol Oncol 1993;50(3):330-333.

  20. Montalvo-Esquivel G, García-Rodríguez FM, Herrera-Gómez A, Alcalá-Prieto FJ. Histerectomía radical. Presentación de 24 casos y revisión de la literatura. Rev Inst Nal Cancerol 2000;46(2):99-103.

  21. Solorza LG, Torres LA, Escudero-de los Ríos P, Rendón RU, Ramírez HJ, Muñoz GD, et al. Histerectomía radical como tratamiento del cáncer en cuello uterino. Experiencia interinstitucional en México. GAMO 2004;3(4):31-34

  22. Mikuta JJ. Radical hysterectomy: personal reflections. Gynecol Oncol 1996;60(2):184-187.

  23. Benedetti-Panici P, Maneschi F, Scambia G, Greggi S, Cutillo G, D’Andrea G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996;62(1):19-24.

  24. Girardi F, Lichtenegger W, Tamussino K, Haas J. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol 1989;34(3):206-211.

  25. Levenback C, Coleman RL, Burke TW, Lin WN, Erdman W, Deavers M, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy an pelvic lymphadenectomy. J Clin Oncol 2002;20(3):688-693. Disponible en http://jco.ascopubs.org/ content/20/3/688.long

  26. Metcalf KS, Johnson N, Calvert S, Peel KR. Site specific lymph node metastasis in carcinoma of the cervix: is there a sentinel node? Int J Gynecol Oncol 2000;10(5):411-416.

  27. Benedetti-Panici P, Angioli R, Palaia I, Muzii L, Zullo MA, Manci N, et al. Tailoring the parametrectomy in stages IA2-IBI cervical carcinoma: is it feasible and safe? Gynecol Oncol 2005;96(3):792-798.

  28. Puente R, Guzmán S, Israel E, Poblete MT. Do the pelvic lymph nodes predict the parametrial status in cervical cancer stages IB-IIA? Int J Gynecol Cancer 2004;14(5): 832-840.

  29. Averette HE, Nguyen HN, Donato DM, Penalver MA, Servin BU, Estape R, et al. Radical hysterectomy for invasive cervical cancer: a 25-year prospective experience with the Miami technique. Cancer 1993;71(Suppl 4):1422-1437.

  30. Barragán-Curiel E, López-Graniel CM, Suchil-Bernal L, Chanona-Vilchis G, Solorza-Luna G. Factores pronósticos en pacientes con cáncer cervicouterino epidermoide tratadas con histerectomía radical tipo III. Rev Inst Nal Cancerol 1999;45(4):217-224.

  31. Saleh-Montalvo T, Reyna-Hinojosa R, Colorado-Murguía S, Saldaña-Ibarra P. [Radical hysterectomy with pelvic lymphadenectomy for the treatment of invasive IB and IIA cervical cancer: review of 153 cases]. Ginecol Obstet Mex 1991;59(6):177-180.

  32. López-Graniel C, Reyes M, Chanona G, González A, Robles E, Mohar A, et al. Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. Int J Gynecol Cancer 2001;11(3):210- 217.

  33. Solorza-Luna G, Muñoz-González D, Botello-Hernández D, Barragán-Curiel E, León-Villalba JC, Frías-Mendivil M, et al. Tratamiento quirúrgico del cáncer del cuello uterino etapa clínica IB1: experiencia del Instituto Nacional de Cancerología de México (1980-1994). Ann Oncol (edición española) 1998;7(Supl):s257-s260.

  34. Dueñas A, Mota A, López-Graniel C, Solorza G, González A, Hinojosa LM, et al. Quimioterapia neoadyuvante en pacientes con carcinoma epidermoide de cérvix estadios IB2 a IIA. Resultados preliminares de un estudio aleatorio. Rev Inst Nal Cancerol 2000;46(1):21-27.

  35. Dueñas-González A, López-Graniel C, González-Enciso A, Cetina L, Rivera L, Mariscal I, et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 2003;14(8):1278-1284.

  36. Morales-Palomares MA, Torres-Lobatón A, Oliva-Posadas JC, Morales-Montes TM, Hurtado-Estrada G, Román- Basure E. Histerectomía radical modificada en pacientes con cáncer cervicouterino IB1. GAMO 2009;8(4):135-141.

  37. Suárez CM, Briceño JM, Medina F, Anzola F, Rezic M, Calde-raro F, et al. Intraoperative lymphatic mapping and identification of the sentinel lymph node in patients with early stages uterine neck carcinoma. Rev Venez Oncol 2005;17(1):2-17.

  38. Vieira SC, Zeferino LC, Silva BB, Santana JO, Ibiapina de, Santos LG, et al. Sentinel node study with patent blue in cervical cancer. Rev Assoc Med Bras 2004;50(3):302- 304.

  39. Smith HO, Qualls CR, Romero AA, Webb JC, Dorin MH, Padilla LA, et al. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix? Gynecol Oncol 2002;85(2):229-241.

  40. Jackson KS, Das N, Naik R, Lopes AD, Godfrey KA, Hatem MH, et al. Laparoscopically assisted radical vaginal hysterectomy vs radical abdominal hysterectomy for cervical cancer: a match controlled study. Gynecol Oncol 2004;95 (3);655-661.




2020     |     www.medigraphic.com